Prices delayed by at least 15 minutes | Print
Creo Medical Group PLC (CREO)
ORD GBP0.001Open
9.75p
Previous close
9.75p
Trade high
10.00p
Volume
507,672
Year high
37.20p
Year low
9.221p
Dividend yield
–
Market capitalisation
£39.60 mn
P/E ratio
–
ISIN
GB00BZ1BLL44
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy. Geographically, the company generates a majority of its revenue from Europe and the rest from the United Kingdom and the rest of the world.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 25/04/2025 | 04:27:28 | 9.6 | 22,748 | 2,183.81 |
| 25/04/2025 | 03:56:31 | 9.6 | 8,038 | 771.65 |
| 25/04/2025 | 03:45:55 | 9.75 | 38,639 | 3,767.30 |
| 25/04/2025 | 03:39:12 | 9.56 | 1,700 | 162.52 |
| 25/04/2025 | 03:15:19 | 9.9705 | 150 | 14.96 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.